STOCK TITAN

Privia Health Group (PRVA) Financials

PRVA NASDAQ
Trailing 12 months to September 30, 2026
Revenue $2.4B +19.2% YoY
Net Income $34.8M +91.3% YoY
EPS (Diluted) $0.26 +100.0% YoY
Operating Cash Flow $108.1M -2.4% YoY
Market Cap $3.2B as of Nov 17, 2026
Price / Sales 1.3x on $2.4B revenue, trailing 12 months to September 30, 2026
Price / Earnings 91.9x on $34.8M net income, trailing 12 months to September 30, 2026
Price / Book 3.9x on $815.7M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PRVA SEC filings page.

Privia Health Group, Inc. (PRVA) reported $2.4B in revenue over the twelve months to Sep 30, 2026, up 19.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PRVA FY2025

Privia’s growth is becoming more profitable and cash-generative, but expansion is absorbing cash while short-term liabilities rise faster than assets.

FY2025 net income was $22.9M versus operating cash flow of $163.4M, revealing a cash conversion gap far larger than the income statement suggests. Operating cash flow equaled 713.0% of net income while receivables grew 26.8%, so the conversion reflects noncash items and working-capital movements rather than profit alone.

Revenue grew 22.3% while SG&A grew only 8.3%, showing operating expenses did not rise in step with the top line. That operating leverage helped operating income grow 101.6% and lifted operating margin to 1.6%, although profitability remains thin.

Liabilities expanded 27.9% versus equity at 16.1%, indicating growth is increasingly financed by obligations rather than retained capital. Current liabilities also expanded faster than current assets, while investing outflows of $181.6M exceeded operating cash flow of $163.4M, indicating cash deployment outpaced internal cash generation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 44 / 100
Financial Health Score 44/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Privia Health Group, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
30

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Privia Health Group, Inc. scores 30/100 on it among other operating companies.

Growth
72

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Privia Health Group, Inc. scores 72/100 on it among other operating companies.

Leverage
39

Privia Health Group, Inc. carried $0.78 of total liabilities for every $1 of shareholders' equity at the end of fiscal year 2025. With no long-term debt figure for fiscal year 2025, Privia Health Group, Inc. is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 39/100 among other operating companies measured the same way.

Liquidity
46

Privia Health Group, Inc. held $1.60 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.60. Liquidity ranks operating companies on that ratio, and Privia Health Group, Inc. scores 46/100 among other operating companies.

Cash Flow
45

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Privia Health Group, Inc. scores 45/100 on it among other operating companies.

Returns
33

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Privia Health Group, Inc. scores 33/100 on it among other operating companies.

Altman Z-Score Safe
5.09

Privia Health Group, Inc. scores 5.09, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $3.2B against total liabilities of $578.4M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/7

Privia Health Group, Inc. passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality Cash-Backed
7.13x

For every $1 of reported earnings, Privia Health Group, Inc. generates $7.13 in operating cash flow ($163.4M OCF vs $22.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$657.0M
YoY+13.2%
QoQ+3.8%
5Y CAGR+21.2%

Privia Health Group, Inc. generated $657.0M in revenue in Q3 2026. This represents an increase of 13.2% from the same quarter a year earlier. Against the prior quarter it is up 3.8%.

EBITDA
$24.0M
YoY+40.0%
QoQ+58.9%
5Y CAGRn/m

Privia Health Group, Inc.'s EBITDA was $24.0M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 40.0% from the same quarter a year earlier. Against the prior quarter it is up 58.9%.

Net Income
$13.5M
YoY+96.6%
QoQ+49.1%
5Y CAGRn/m

Privia Health Group, Inc. reported $13.5M in net income in Q3 2026. This represents an increase of 96.6% from the same quarter a year earlier. Against the prior quarter it is up 49.1%.

EPS (Diluted)
$0.10
YoY+100.0%
QoQ+42.9%
5Y CAGRn/m

Privia Health Group, Inc. earned $0.10 per diluted share (EPS) in Q3 2026. This represents an increase of 100.0% from the same quarter a year earlier. Against the prior quarter it is up 42.9%.

Cash & Balance Sheet

Cash & Debt
$446.3M
YoY+1.1%
QoQ+8.3%
5Y CAGR+4.3%

Privia Health Group, Inc. held $446.3M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Shares Outstanding
128M
YoY+3.9%
QoQ0.0%
5Y CAGR+3.7%

Privia Health Group, Inc. had 128M shares outstanding in Q3 2026. This represents an increase of 3.9% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Operating Margin
3.1%
YoY+0.7pp
QoQ+1.3pp
5Y change+8.2pp

Privia Health Group, Inc.'s operating margin was 3.1% in Q3 2026, reflecting core business profitability. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Net Margin
2.1%
YoY+0.9pp
QoQ+0.6pp
5Y change+5.7pp

Privia Health Group, Inc.'s net profit margin was 2.1% in Q3 2026, showing the share of revenue converted to profit. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Return on Equity
1.7%
YoY+0.7pp
QoQ+0.5pp
5Y change+3.9pp

Privia Health Group, Inc.'s quarterly ROE was 1.7% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

PRVA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRVA quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$657.0M+13.2%$632.6M+21.4%$603.8M+25.8%$541.2M+17.4%$580.4M+32.5%$521.2M+23.4%$480.1M+15.6%$460.9M+4.6%
SG&A Expenses$44.4M-4.7%$47.7M+7.5%$49.6M+28.4%$35.7M-12.6%$46.6M+23.5%$44.3M+23.9%$38.6M+1.1%$40.9M+14.1%
Operating Income$20.5M+42.6%$11.8M+252.9%$7.4M+42.2%$11.3M+114.9%$14.4M+147.8%$3.3M-34.6%$5.2M+534.0%$5.2M+269.6%
EBITDA$24.0M+40.0%$15.1M+155.6%$10.7M+50.3%$13.9M+96.8%$17.2M+125.6%$5.9M-14.4%$7.1M+169.3%$7.1M+121.8%
Income Tax$7.7M+11.7%$7.0M+185.7%$5.6M+166.3%$2.8M+4.9%$6.9M+71.7%$2.5M-28.2%$2.1M+180.0%$2.7M+36.6%
Net Income$13.5M+96.6%$9.0M+236.7%$3.1M-27.4%$9.2M+108.0%$6.9M+94.1%$2.7M-22.5%$4.2M+41.4%$4.4M+55.0%
EPS (Basic)$0.11+83.3%$0.07+250.0%$0.02-33.3%$0.08+100.0%$0.06+100.0%$0.02-33.3%$0.030.0%$0.04+33.3%
EPS (Diluted)$0.10+100.0%$0.07+250.0%$0.02-33.3%$0.07+133.3%$0.05+66.7%$0.02-33.3%$0.03+50.0%$0.030.0%
Diluted Shares (Avg)133M+3.1%132M+2.6%131M+2.4%N/A129M+2.4%128M+2.5%128M+2.2%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense.

PRVA Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRVA quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$1.6B+15.7%$1.5B+17.0%$1.4B+19.8%$1.4B+20.6%$1.4B+17.9%$1.3B+18.1%$1.2B+14.7%$1.1B+13.6%
Current Assets$1.1B+13.2%$1.0B+16.1%$966.0M+9.0%$911.0M+9.1%$970.9M+13.7%$883.0M+13.2%$886.5M+21.7%$834.8M+19.1%
Cash & Equivalents$446.3M+1.1%$412.2M+5.7%$419.5M-10.6%$479.7M-2.3%$441.4M+4.6%$390.1M+0.7%$469.3M+33.7%$491.1M+26.1%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Accounts Receivable$623.6M+25.0%$574.2M+29.3%$513.7M+32.1%$400.9M+26.8%$499.0M+22.0%$444.0M+20.0%$388.7M+12.3%$316.2M+8.7%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$215.8M+25.3%$215.8M+25.3%$209.8M+48.2%$209.8M+48.2%$172.2M+23.5%$172.2M+23.5%$141.6M+1.5%$141.6M+2.1%
Total Liabilities$690.8M+17.4%$650.5M+20.7%$612.0M+29.1%$578.4M+27.9%$588.2M+21.7%$539.0M+24.2%$474.0M+16.0%$452.3M+15.2%
Current Liabilities$674.4M+15.7%$634.4M+18.6%$601.3M+27.7%$568.5M+26.6%$582.9M+21.6%$534.9M+24.5%$470.8M+16.6%$449.1M+16.1%
Non-Current Liabilities$16.4M+209.6%$16.1M+287.8%$10.7M+233.9%$9.9M+210.8%$5.3M+35.9%$4.1M-6.3%$3.2M-35.5%$3.2M-42.6%
Total Equity$815.7M+15.0%$782.3M+14.6%$753.1M+14.2%$737.2M+16.1%$709.1M+15.3%$682.9M+14.7%$659.4M+14.3%$635.2M+13.1%
Retained Earnings-$130.7Mn/m-$144.2Mn/m-$153.2Mn/m-$156.3Mn/m-$165.5Mn/m-$172.3Mn/m-$175.0Mn/m-$179.2Mn/m

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

PRVA Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRVA quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$28.9M-44.3%$1.1M-86.2%-$49.5Mn/m$127.5M+70.5%$52.0M+56.8%$8.0M-76.9%-$24.1Mn/m$74.8M+16.7%
Depreciation & Amortization$3.5M+26.6%$3.4M+29.9%$3.3M+72.6%$2.7M+45.0%$2.8M+53.9%$2.6M+42.1%$1.9M+4.4%$1.8M+3.4%
Stock-Based Compensation$14.0M-26.1%$19.4M+2.9%$21.9M+23.2%N/A$19.0M+25.6%$18.8M+31.0%$17.8M+49.4%N/A
Investing Cash Flow-$1.1Mn/m-$11.5Mn/m-$26Kn/m-$91.3Mn/m-$1.2Mn/m-$89.1Mn/m$0n/m-$6.3Mn/m
Financing Cash Flow$6.2M+1342.0%$3.0M+61.4%-$10.7M-575.7%$2.1M+246.5%$431K-71.1%$1.9M+7.7%$2.2M+372.2%$619K+1373.8%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

PRVA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRVA quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Margin3.1%+0.7pp1.9%+1.2pp1.2%+0.1pp2.1%+0.9pp2.5%+1.1pp0.6%-0.6pp1.1%+0.9pp1.1%+0.8pp
Net Margin2.1%+0.9pp1.4%+0.9pp0.5%-0.4pp1.7%+0.7pp1.2%+0.4pp0.5%-0.3pp0.9%+0.2pp0.9%+0.3pp
Return on Equity1.7%+0.7pp1.2%+0.8pp0.4%-0.2pp1.2%+0.5pp1.0%+0.4pp0.4%-0.2pp0.6%+0.1pp0.7%+0.2pp
Return on Assets0.9%+0.3pp0.6%+0.4pp0.2%-0.1pp0.7%+0.3pp0.5%+0.2pp0.2%-0.1pp0.4%+0.1pp0.4%+0.1pp
Current Ratio1.630.0x1.620.0x1.61-0.3x1.60-0.3x1.67-0.1x1.65-0.2x1.88+0.1x1.860.0x
Liabilities-to-Equity0.850.0x0.830.0x0.81+0.1x0.78+0.1x0.830.0x0.79+0.1x0.720.0x0.710.0x
Asset Turnover0.420.0x0.430.0x0.430.0x0.400.0x0.430.0x0.410.0x0.410.0x0.410.0x

Not reported in any period shown, so not listed: Gross Margin, Debt-to-Equity, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Privia Health Group, Inc. PRVA FY2025 $2.1B $22.9M 1.1% $3.2B 44/100
Heartflow, Inc. HTFL FY2025 $176.0M -$116.8M -66.3% $4.1B 60/100
Waystar Holding Corp. WAY FY2025 $1.1B $112.1M 10.2% $5.3B 60/100
Schrodinger, Inc. SDGR FY2025 $255.9M -$103.3M -40.4% $1.9B 73/100
Doximity, Inc. DOCS FY2026 $644.9M $196.1M 30.4% $5.6B 89/100
HealthEquity, Inc HQY FY2026 $1.3B $215.2M 16.4% $8.4B 70/100

Frequently Asked Questions

Privia Health Group, Inc. (PRVA) reported $2.1B in total revenue for fiscal year 2025. This represents a 22.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Privia Health Group, Inc. (PRVA) revenue grew by 22.3% year-over-year, from $1.7B to $2.1B in fiscal year 2025.

Yes, Privia Health Group, Inc. (PRVA) reported a net income of $34.8M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $22.9M, with a net profit margin of 1.1%.

Privia Health Group, Inc. (PRVA) reported diluted earnings per share of $0.18 for fiscal year 2025. This represents a 63.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Privia Health Group, Inc. (PRVA) had EBITDA of $44.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Privia Health Group, Inc. (PRVA) had an operating margin of 1.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Privia Health Group, Inc. (PRVA) had a net profit margin of 1.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Privia Health Group, Inc. (PRVA) has a return on equity of 3.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Privia Health Group, Inc. (PRVA) generated $163.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Privia Health Group, Inc. (PRVA) had $1.4B in total assets as of fiscal year 2025, including both current and long-term assets.

Privia Health Group, Inc. (PRVA) had 124M shares outstanding as of fiscal year 2025.

Privia Health Group, Inc. (PRVA) had a current ratio of 1.60 as of fiscal year 2025, which is generally considered healthy.

Privia Health Group, Inc. (PRVA) had a liabilities-to-equity ratio of 0.78 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Privia Health Group, Inc. (PRVA) had a return on assets of 1.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Privia Health Group, Inc. (PRVA) trades at 91.9x earnings, its market capitalization divided by $34.8M net income, trailing 12 months to September 30, 2026. The market capitalization is $3.2B as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Privia Health Group, Inc. (PRVA) trades at 1.3x sales, its market capitalization divided by $2.4B revenue, trailing 12 months to September 30, 2026. The market capitalization is $3.2B as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Privia Health Group, Inc. (PRVA) has an Altman Z-Score of 5.09, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Privia Health Group, Inc. (PRVA) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Privia Health Group, Inc. (PRVA) has an earnings quality ratio of 7.13x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Privia Health Group, Inc. (PRVA) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top